BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 26606148)

  • 1. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    J Miss State Med Assoc; 2015 Dec; 56(12):364-71. PubMed ID: 26975161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.
    Finlayson T; Cha S; Xia M; Trujillo L; Denson D; Prejean J; Kanny D; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(27):597-603. PubMed ID: 31298662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.
    Hoots BE; Finlayson T; Nerlander L; Paz-Bailey G;
    Clin Infect Dis; 2016 Sep; 63(5):672-7. PubMed ID: 27282710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015.
    Smith DK; Van Handel M; Grey J
    Ann Epidemiol; 2018 Dec; 28(12):850-857.e9. PubMed ID: 29941379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
    Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
    MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
    Walters SM; Rivera AV; Starbuck L; Reilly KH; Boldon N; Anderson BJ; Braunstein S
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3():S383-S391. PubMed ID: 28604443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.
    Jenness SM; Goodreau SM; Rosenberg E; Beylerian EN; Hoover KW; Smith DK; Sullivan P
    J Infect Dis; 2016 Dec; 214(12):1800-1807. PubMed ID: 27418048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying National Estimates of Adults With Indications for Pre-Exposure Prophylaxis to Populations of Men Who Have Sex With Men and People Who Inject Drugs in Colorado: Modeling Study.
    Donnelly JA; Deem TT; Duffy MA; Watkins AK; Al-Tayyib AA; Shodell DJ; Thrun M; Rowan SE
    JMIR Public Health Surveill; 2019 Jan; 5(1):e11113. PubMed ID: 30664481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
    Adams LM; Balderson BH
    AIDS Care; 2016 Sep; 28(9):1154-8. PubMed ID: 26915281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
    Wu H; Mendoza MC; Huang YA; Hayes T; Smith DK; Hoover KW
    Clin Infect Dis; 2017 Jan; 64(2):144-149. PubMed ID: 27986691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Number of Men Who Have Sex With Men With Indications for HIV Pre-exposure Prophylaxis in a National Sexual Network Study.
    Weiss KM; Prasad P; Ramaraju R; Zlotorzynska M; Jenness SM
    J Acquir Immune Defic Syndr; 2020 May; 84(1):10-17. PubMed ID: 31939869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth in Proportion and Disparities of HIV PrEP Use Among Key Populations Identified in the United States National Goals: Systematic Review and Meta-analysis of Published Surveys.
    Kamitani E; Johnson WD; Wichser ME; Adegbite AH; Mullins MM; Sipe TA
    J Acquir Immune Defic Syndr; 2020 Aug; 84(4):379-386. PubMed ID: 32205721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of PrEP Awareness, PrEP Discussion with a Provider, and PrEP Use by Transmission Risk Group with an Emphasis on the Southern United States.
    Jones JT; Smith DK; Wiener J; August EM; Finlayson T; Wejnert C;
    AIDS Behav; 2021 Sep; 25(9):2985-2991. PubMed ID: 33523345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using data from a behavioural survey of men who have sex with men (MSM) to estimate the number likely to present for HIV pre-exposure prophylaxis (PrEP) in Ireland, 2017.
    Nic Lochlainn L; O'Donnell K; Hurley C; Lyons F; Igoe D
    Euro Surveill; 2017 Nov; 22(48):. PubMed ID: 29208157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.
    Juusola JL; Brandeau ML; Owens DK; Bendavid E
    Ann Intern Med; 2012 Apr; 156(8):541-50. PubMed ID: 22508731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018.
    Harris NS; Johnson AS; Huang YA; Kern D; Fulton P; Smith DK; Valleroy LA; Hall HI
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(48):1117-1123. PubMed ID: 31805031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial, Ethnic, and Gender Disparities in Awareness of Preexposure Prophylaxis Among HIV-Negative Heterosexually Active Adults at Increased Risk for HIV Infection - 23 Urban Areas, United States, 2019.
    Baugher AR; Trujillo L; Kanny D; Freeman JQ; Hickey T; Sionean C; Respress E; Chapin-Bardales J; Marcus R; Finlayson T; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(47):1635-1639. PubMed ID: 34818317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.